Exelixis, Inc.
EXEL
$37.70
-$0.58-1.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.23B | 2.30B | 2.17B | 2.08B | 2.01B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.23B | 2.30B | 2.17B | 2.08B | 2.01B |
| Cost of Revenue | 75.94M | 74.13M | 76.22M | 78.00M | 79.45M |
| Gross Profit | 2.15B | 2.22B | 2.09B | 2.00B | 1.93B |
| SG&A Expenses | 518.17M | 515.33M | 492.13M | 489.24M | 515.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.48B | 1.48B | 1.48B | 1.47B | 1.61B |
| Operating Income | 751.74M | 814.51M | 689.95M | 608.28M | 402.85M |
| Income Before Tax | 775.63M | 838.06M | 681.64M | 599.91M | 450.97M |
| Income Tax Expenses | 173.34M | 194.50M | 160.37M | 132.98M | 100.98M |
| Earnings from Continuing Operations | 602.30 | 643.57 | 521.27 | 466.92 | 349.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 602.30M | 643.57M | 521.27M | 466.92M | 349.99M |
| EBIT | 751.74M | 814.51M | 689.95M | 608.28M | 402.85M |
| EBITDA | 781.52M | 844.28M | 718.75M | 635.96M | 429.38M |
| EPS Basic | 2.16 | 2.26 | 1.81 | 1.60 | 1.19 |
| Normalized Basic EPS | 1.85 | 1.95 | 1.66 | 1.47 | 1.02 |
| EPS Diluted | 2.08 | 2.20 | 1.77 | 1.56 | 1.17 |
| Normalized Diluted EPS | 1.79 | 1.91 | 1.63 | 1.44 | 1.01 |
| Average Basic Shares Outstanding | 1.12B | 1.14B | 1.16B | 1.18B | 1.21B |
| Average Diluted Shares Outstanding | 1.16B | 1.17B | 1.18B | 1.20B | 1.23B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |